JPL Wealth Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
EAM
ACG
JMFC
JPL Wealth Management's DNA Position: Q2 2026 in Review
JPL Wealth Management opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 7 shares worth $70. The stake represents ﹤0.01% of the portfolio and ranks #1672 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in DNA as recently as Q2 2024.
JPL Wealth Management first reported a position in DNA in Q1 2024 and has held it in 3 quarters since. The position peaked at $11.6K in Q1 2024. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.
- JPL Wealth Management held 7 shares of Ginkgo Bioworks worth $70 as of Q2 2026.
- Ginkgo Bioworks was a new JPL Wealth Management position in Q2 2026.
- Ginkgo Bioworks made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1672 holding.
- JPL Wealth Management first reported a position in Ginkgo Bioworks in Q1 2024 and has held it in 3 quarters since.
- JPL Wealth Management's Ginkgo Bioworks position peaked at $11.6K in Q1 2024.
- 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.
Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.